Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2024	Dec. 31, 2023
Current assets:
Cash and cash equivalents	$ 36,997	$ 135,704
Restricted cash	110	70
Short-term investments	19,942
Other current assets	5,092	5,310
Total current assets	62,141	141,084
Operating lease right-of-use assets	4,964	6,559
Property and equipment, net	2,362	3,259
Other assets	627	625
Total assets	70,094	151,527
Current liabilities:
Accounts payable	2,571	2,517
Accrued liabilities	15,557	16,842
Operating lease liabilities, current	3,422	3,229
Finance lease liabilities, current	36	10
Deferred revenue, current	151	1,308
Total current liabilities	21,737	23,906
Operating lease liabilities, net of current portion	4,795	7,668
Finance lease liabilities, net of current portion	122	231
Common warrant liability	72,367	27,596
Long term liability	46	46
Total liabilities	99,067	59,447
Commitments and contingencies (Note 14)
Stockholders' (deficit) equity:
Preferred Stock, $0.0001 par value; 10,000,000 shares authorized as of December 31, 2024 and December 31, 2023, respectively; no shares issued and outstanding as of December 31, 2024 and December 31, 2023, respectively.
Common stock, $0.0001 par value; 20,800,000 shares and 12,800,000 shares authorized as of December 31, 2024 and December 31, 2023, respectively; 3,864,436 and 3,003,855 shares issued and outstanding as of December 31, 2024 and December 31, 2023, respectively.	8	7
Additional paid-in capital	588,576	578,325
Accumulated deficit	(618,008)	(486,797)
Accumulated other comprehensive income	451	545
Total stockholders' (deficit) equity	(28,973)	92,080
Total liabilities and stockholders' (deficit) equity	$ 70,094	$ 151,527